Ttbio Corp. (TPEX:6493)

Ttbio Statistics

Total Valuation

Ttbio has a market cap or net worth of TWD 1.62 billion. The enterprise value is 1.77 billion.

Market Cap	1.62B
Enterprise Value	1.77B

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	Jul 28, 2025

Share Statistics

Ttbio has 30.05 million shares outstanding. The number of shares has increased by 42.15% in one year.

Current Share Class	30.05M
Shares Outstanding	30.05M
Shares Change (YoY)	+42.15%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	5.78%
Float	10.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.12
PB Ratio	5.64
P/TBV Ratio	6.52
P/FCF Ratio	67.38
P/OCF Ratio	55.31
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 45.89, with an EV/FCF ratio of 73.78.

EV / Earnings	-9,172.99
EV / Sales	4.51
EV / EBITDA	45.89
EV / EBIT	n/a
EV / FCF	73.78

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.95.

Current Ratio	1.61
Quick Ratio	0.69
Debt / Equity	0.95
Debt / EBITDA	7.04
Debt / FCF	11.33
Interest Coverage	0.79

Financial Efficiency

Return on equity (ROE) is -0.07% and return on invested capital (ROIC) is 0.51%.

Return on Equity (ROE)	-0.07%
Return on Assets (ROA)	0.45%
Return on Invested Capital (ROIC)	0.51%
Return on Capital Employed (ROCE)	1.16%
Revenue Per Employee	3.33M
Profits Per Employee	-1,636
Employee Count	118
Asset Turnover	0.64
Inventory Turnover	1.43

Taxes

Income Tax	-181,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +172.73% in the last 52 weeks. The beta is 0.44, so Ttbio's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+172.73%
50-Day Moving Average	23.87
200-Day Moving Average	19.75
Relative Strength Index (RSI)	72.03
Average Volume (20 Days)	330,686

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ttbio had revenue of TWD 392.72 million and -193,000 in losses. Loss per share was -0.01.

Revenue	392.72M
Gross Profit	81.66M
Operating Income	4.43M
Pretax Income	-374,000
Net Income	-193,000
EBITDA	30.83M
EBIT	4.43M
Loss Per Share	-0.01

Balance Sheet

The company has 118.04 million in cash and 271.74 million in debt, giving a net cash position of -153.70 million or -5.11 per share.

Cash & Cash Equivalents	118.04M
Total Debt	271.74M
Net Cash	-153.70M
Net Cash Per Share	-5.11
Equity (Book Value)	286.46M
Book Value Per Share	11.99
Working Capital	157.31M

Cash Flow

In the last 12 months, operating cash flow was 29.23 million and capital expenditures -5.24 million, giving a free cash flow of 23.99 million.

Operating Cash Flow	29.23M
Capital Expenditures	-5.24M
Free Cash Flow	23.99M
FCF Per Share	0.80

Margins

Gross margin is 20.79%, with operating and profit margins of 1.13% and -0.05%.

Gross Margin	20.79%
Operating Margin	1.13%
Pretax Margin	-0.10%
Profit Margin	-0.05%
EBITDA Margin	7.85%
EBIT Margin	1.13%
FCF Margin	6.11%

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.52%.

Dividend Per Share	0.25
Dividend Yield	0.52%
Dividend Growth (YoY)	-33.31%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.15%
Shareholder Yield	-41.63%
Earnings Yield	-0.01%
FCF Yield	1.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5